AnneMarie Vos

471 total citations
8 papers, 350 citations indexed

About

AnneMarie Vos is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Neurology. According to data from OpenAlex, AnneMarie Vos has authored 8 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Surgery and 2 papers in Neurology. Recurrent topics in AnneMarie Vos's work include Sarcoma Diagnosis and Treatment (4 papers), Testicular diseases and treatments (4 papers) and Neuroblastoma Research and Treatments (2 papers). AnneMarie Vos is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Testicular diseases and treatments (4 papers) and Neuroblastoma Research and Treatments (2 papers). AnneMarie Vos collaborates with scholars based in Netherlands. AnneMarie Vos's co-authors include Bauke M. de Jong, J. Wolter Oosterhuis, Sérgio Castedo, Gerard J. te Meerman, Heimen Schraffordt Koops, Anke Dam, Anke van den Berg, Hendrik J.M. de Jonge, Carolien M. Woolthuis and E. S. J. M. de Bont and has published in prestigious journals such as Leukemia and Cancer Genetics and Cytogenetics.

In The Last Decade

AnneMarie Vos

8 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
AnneMarie Vos Netherlands 7 196 169 88 70 45 8 350
Darshna Dudakia United Kingdom 7 251 1.3× 185 1.1× 99 1.1× 97 1.4× 37 0.8× 10 363
R. J. H. L. M. van Gurp Netherlands 6 301 1.5× 351 2.1× 168 1.9× 85 1.2× 69 1.5× 8 554
Jannie van Echten Netherlands 15 506 2.6× 307 1.8× 243 2.8× 195 2.8× 30 0.7× 24 681
Rachel Linger United Kingdom 4 338 1.7× 327 1.9× 256 2.9× 75 1.1× 44 1.0× 7 557
M. Kiechle‐Schwarz Germany 12 54 0.3× 102 0.6× 72 0.8× 38 0.5× 81 1.8× 23 319
Sira Moreno Spain 9 34 0.2× 158 0.9× 95 1.1× 44 0.6× 101 2.2× 17 350
Martin A. Rijlaarsdam Netherlands 11 346 1.8× 340 2.0× 56 0.6× 124 1.8× 140 3.1× 12 542
Ângelo Rodrigues Portugal 9 203 1.0× 209 1.2× 16 0.2× 101 1.4× 77 1.7× 22 367
Ewa Rajpert-De Meyts Denmark 6 195 1.0× 272 1.6× 115 1.3× 41 0.6× 55 1.2× 6 429
Mariola Iliszko Poland 12 88 0.4× 117 0.7× 72 0.8× 189 2.7× 44 1.0× 27 363

Countries citing papers authored by AnneMarie Vos

Since Specialization
Citations

This map shows the geographic impact of AnneMarie Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AnneMarie Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AnneMarie Vos more than expected).

Fields of papers citing papers by AnneMarie Vos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AnneMarie Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AnneMarie Vos. The network helps show where AnneMarie Vos may publish in the future.

Co-authorship network of co-authors of AnneMarie Vos

This figure shows the co-authorship network connecting the top 25 collaborators of AnneMarie Vos. A scholar is included among the top collaborators of AnneMarie Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AnneMarie Vos. AnneMarie Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Jonge, Hendrik J.M. de, Carolien M. Woolthuis, AnneMarie Vos, et al.. (2011). Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML. Leukemia. 25(12). 1825–1833. 72 indexed citations
2.
Berg, Anke van den, Jasper J. van Doormaal, J. Wolter Oosterhuis, et al.. (1991). Chromosomal aberrations in follicular thyroid carcinoma. Cancer Genetics and Cytogenetics. 54(2). 215–222. 19 indexed citations
3.
Berg, Anke van den, et al.. (1990). Cytogenetics of thyroid follicular adenomas. Cancer Genetics and Cytogenetics. 44(2). 217–222. 34 indexed citations
4.
Vos, AnneMarie, et al.. (1990). Karyotyping and DNA flow cytometry of metastatic ovarian yolk sac tumor. Cancer Genetics and Cytogenetics. 44(2). 223–228. 11 indexed citations
5.
Vos, AnneMarie, et al.. (1990). Cytogenetics of carcinoma in situ of the testis. Cancer Genetics and Cytogenetics. 46(1). 75–81. 58 indexed citations
6.
Jong, Bauke M. de, J. Wolter Oosterhuis, Sérgio Castedo, AnneMarie Vos, & Gerard J. te Meerman. (1990). Pathogenesis of adult testicular germ cell tumors. Cancer Genetics and Cytogenetics. 48(2). 143–167. 135 indexed citations
7.
Oosterhuis, J. Wolter, Sérgio Castedo, Bauke M. de Jong, et al.. (1989). A malignant mixed gonadal stromal tumor of the testis with heterologous components and i(12p) in one of its metastases. Cancer Genetics and Cytogenetics. 41(1). 105–114. 19 indexed citations
8.
Berg, Anke van den, Klaas Kok, AnneMarie Vos, et al.. (1989). 131 Are chromosome 3 deletions a consistent abnormality in mesotheliomas?. Cancer Genetics and Cytogenetics. 38(2). 203–203. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026